Biosafety and Biosecurity Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 16.50 Bn

Forecast Year, 2035

USD 42.02 Bn

CAGR, 2026 - 2035

9.80%

Report Coverage

Global

What is the Biosafety and Biosecurity Market Size in 2026?

The global biosafety and biosecurity market size accounted for USD 16.50 billion in 2025 and is predicted to increase from USD 18.12 billion in 2026 to approximately USD 42.02 billion by 2035, expanding at a CAGR of 9.80% from 2026 to 2035. The biosafety and biosecurity market is driven by a growing focus on protecting public health and the environment by ensuring the safe handling of biological materials. As the demand for advanced safety protocols and protective measures grows, this market is poised for significant expansion.

Key Takeaways

• North America dominated the biosafety and biosecurity market, holding the largest share in 2025.
• The Asia Pacific is expected to expand at the fastest CAGR in the market between 2026 and 2035.
• By product type, the biocides & disinfectants segment led the market with 28% in 2025.
• By product type, the personal protective equipment (PPE) segment held the second largest market share of 22% in 2025.
• By end-user type, the government & regulatory bodies segment led the global market in 2025 with 26%.
• By end-user type, the healthcare institutions segment held the second-largest position with 24% share in 2025.
• By distribution channel type, the direct sales segment led the global market in 2025 with 34%.
• By distribution channel type, the distributors & dealers segment held the second largest share of 26% in 2025.
• By application type, the healthcare & infection control segment led the global market in 2025 with 30%.
• By application type, the agricultural biosecurity segment held the second-largest position with a 20% share in 2025.

Market Overview

The biosafety and biosecurity market refers to technologies, equipment, and services designed to protect humans, animals, and the environment from exposure to harmful biological agents, pathogens, and toxins. This includes laboratory safety practices, containment equipment, diagnostic and decontamination systems, and regulatory compliance solutions. The market is critical in research laboratories, healthcare facilities, biopharmaceutical production, and biodefense to prevent accidental or intentional release of infectious agents. Growth is driven by rising infectious disease prevalence, stringent government regulations, increasing laboratory infrastructure, and pandemic preparedness initiatives.

The biosafety and biosecurity market encompasses a range of products and services designed to mitigate risks associated with biological threats. With the increasing incidence of pandemics and bioterrorism, regulatory bodies are implementing stricter safety standards. Technological advancements in monitoring and prevention are transforming how organizations approach biosafety. Additionally, research institutions and healthcare sectors are investing heavily in developing robust biosecurity measures. Collaboration between public and private entities is essential for establishing comprehensive frameworks. As awareness of potential biological threats continues to rise, the market is set for sustained growth and innovation.

Key Technological Shift in the Market

The most consequential technological pivot is the integration of real-time biosurveillance, rapid molecular diagnostics , and secure digital platforms converging wet-lab workflows with data analytics and cyber protections. Rapid nucleic-acid amplification technologies and multiplexed biosensors enable near-instant detection across clinical and environmental matrices. At the same time, modular high-containment facilities and negative-pressure micro-environments allow rapid surge capacity without permanent infrastructure buildouts. Digital twins and secure cloud platforms permit remote monitoring, predictive maintenance , and anomaly detection for containment systems. Finally, cyberbiosecurity tools are being woven into LIMS and design software to prevent misuse of sequence data and to protect intellectual property. Together, these shifts convert biosafety from static boxes and PPE into dynamic, networked systems that detect, respond, and learn.

Key Market Trends

• Proliferation of modular BSL-2+/BSL-3 laboratories for scalable surge capacity.
• Convergence of environmental surveillance (wastewater, air samplers) with clinical diagnostics.
• Emphasis on cyberbiosecurity and secure data governance for synthetic biology .
• Growth of disposable-to-reusable PPE hybrids and greener sterilisation modalities.

Market Scope

Market Dynamics

Drivers

Rising Incidence of Infectious Diseases and Global Health Threats

The increasing frequency of outbreaks such as pandemics and emerging infectious diseases is driving demand for biosafety and biosecurity solutions. Governments and healthcare organizations are investing heavily in containment facilities, surveillance systems, and laboratory safety measures to prevent and control biological risks.

Restraint

High Costs

Establishing biosafety laboratories, containment infrastructure, and advanced monitoring systems requires significant capital investment. Additionally, ongoing costs related to compliance, staff training, and equipment maintenance can limit adoption, especially in developing regions.

Opportunity

Expansion of Biotechnology and Life Sciences Research

Rapid growth in biotechnology , pharmaceuticals , and genetic research is creating strong demand for robust biosafety and biosecurity frameworks. Increasing R&D activities, particularly in areas like vaccine development and synthetic biology, are opening new avenues for advanced safety solutions and specialized services.

Segment Insights

Product Insights

Biosafety and Biosecurity Market Share, By Product Type, 2025-2035 (%)

Biocides And Disinfectants Segment Dominated the Market With a 28% Share in 2025

The biocides and disinfectants segment dominated the biosafety and biosecurity market with a 28% share in 2025, driven by high usage of biocides to control the growth of pathogenic microorganisms or eliminate them from inanimate objects, surfaces, and intact skin. Disinfectants are effective in inactivating bacteria, fungi, certain viruses, and mycobacteria on surfaces and skin, further reinforcing the segment's dominance. Their widespread use across homes, educational institutions, and hospitals for cleaning purposes, along with increased household adoption following COVID-19, has further supported segment growth.

The personal protective equipment (PPE) segment held the second-largest position, accounting for approximately 22% of revenue share in 2025. This growth is attributed to its extensive use in minimizing exposure to hazards that can cause serious workplace injuries and illnesses. Healthcare settings rely heavily on PPE, as it protects both providers and recipients of medical care. The segment includes a wide range of products such as eye protection, face masks, gloves, gowns, and head and foot covers, all of which contribute to market expansion.

The detection & monitoring equipment segment held about 20% share of the biosafety and biosecurity market in 2025, driven by the increasing use of these tools to protect both personnel and sensitive materials. Smart monitoring systems have become essential for maintaining safety and operational efficiency. By integrating advanced sensors, data analytics, and automation, these systems offer enhanced visibility into isolator performance, environmental conditions, and potential risks, thereby supporting adoption.

The decontamination systems segment accounted for approximately 18% share in 2025. Its growth is supported by the ability of these systems to decontaminate large numbers of people, including injured individuals. Decontamination systems include a range of techniques and equipment designed to eliminate or neutralize harmful biological, chemical, or radioactive substances, thereby driving adoption.

End-user Insights

Biosafety and Biosecurity Market Share, By End User, 2025-2035 (%)

Government & Regulatory Bodies Segment Held a 26% Market Share in 2025

The government & regulatory bodies segment dominated the biosafety and biosecurity market with nearly 26% share in 2025. This dominance is attributed to the fact that biosafety and biosecurity practices within government and regulatory institutions are governed by strict guidelines and mandates. Due to concerns related to health, safety, human protection, and political security, this area remains under close supervision. In addition, the role of biosecurity in addressing the risk of biological agents continues to support the segment's leadership.

The healthcare institutions segment held the second-largest market share of 24% in 2025, driven by the significant progress healthcare institutions have made in implementing laboratory biosafety and biosecurity programs. The adoption of biosafety and biosecurity requirements, along with the development of the capacity and capabilities needed for effective biorisk management, is essential for protecting human health and ensuring that research outcomes are not compromised by contamination.

The agriculture sector segment held about 18% share of the biosafety and biosecurity market in 2025, driven by the implementation of biosafety and biosecurity measures that help build resilient agricultural systems. These measures safeguard crops against biohazards such as invasive species, support the control and management of zoonotic diseases, and help prevent pathogen infiltration at the international level.

The research & academia segment held about 16% market share in 2025, supported by the need for clear guidelines, policies, standards, and procedures for laboratory personnel handling bacteria, viruses, parasites, and fungi. Based on these guidelines, BSL laboratories are established. In addition, committees develop policies related to risk assessment, risk characterization, and risk evaluation in clinical and research laboratories, further supporting market adoption.

Distribution Channel Insights

The Direct Sales Segment Led the Market in 2025 With a 34% Share

The direct sales segment dominated the biosafety and biosecurity market in 2025 with a 34% share, driven by the strong support, service quality, and cost-effective pricing offered through direct sales. Service teams help ensure smooth operations, from pre-sales consultation and installation to ongoing maintenance and service plans. The channel also supports customization for customers with specific requirements, further enhancing its appeal.

The distributors & dealers segment held the second-largest position, accounting for nearly 26% share in 2025. It is preferred for fulfilling bulk requirements efficiently. It also reduces paperwork, as many operational tasks are managed by distributors and dealers, while ensuring product availability and delivery even in remote areas.

Biosafety and Biosecurity Market Share, By Distribution Channel, 2025-2035 (%)

The government procurement segment held approximately 20% market share in 2025, driven by highly regulated procurement guidelines and processes. Under various government schemes, these products are supplied to higher education and research institutes based on need and the required BSL level. Additionally, government healthcare programs related to biosafety and biosecurity are also implemented through this channel. The availability of government procurement portals has further strengthened adoption.

The online / e-commerce segment held about 12% share of the biosafety and biosecurity market in 2025. Its growth is attributed to the rising routine use of online shopping, especially after the COVID-19 pandemic. Despite the advantages and challenges associated with this mode of trade, the convenience it offers customers and the employment opportunities it has generated have contributed to its adoption.

Application Insights

Healthcare & Infection Control Segment Held a 30% Market Share in 2025

The healthcare & infection control segment dominated the biosafety and biosecurity market with about 30% revenue share in 2025, driven by the need for strict hygiene and sterilization practices to prevent hospital-acquired infections. Healthcare environments often present unique infectious disease risks, making biosafety and biosecurity critical for accurate diagnosis, treatment, and disease monitoring. At the same time, the handling of infectious organisms and potentially infectious materials in laboratories highlights the importance of protecting both laboratory personnel and the broader public.

The agricultural biosecurity segment held the second-largest share of 20% in 2025, supported by strategic frameworks that promote, develop, and strengthen policy and regulatory structures for food, agriculture, fisheries, and forestry. Biosecurity plays a direct role in food safety, environmental conservation, biodiversity protection, and the long-term sustainability of agriculture.

Biosafety and Biosecurity Market Share, By Application, 2025-2035 (%)

The laboratory & research safety segment held about 18% share of the market in 2025. This is mainly due to the proper use of protective equipment and clothing, along with the safe handling of materials in laboratory settings. Government regulations and professional guidelines also address other important aspects of research, including the use of grant funding, sharing of research findings, handling of hazardous materials, and overall laboratory safety.

The industrial & commercial safety segment held about 17% market share in 2025. Its growth is supported by the increasing need to ensure the safety and security of workers and industrial materials. Effective safety measures help maintain protocol compliance and improve employee awareness.

Regional Insights

North America Biosafety and Biosecurity Market Size and Growth 2026 to 2035

The North America biosafety and biosecurity market size is estimated at USD 6.27 billion in 2025 and is projected to reach approximately USD 16.18 billion by 2035, with a 9.94% CAGR from 2026 to 2035.

Why Did North America Dominated the Biosafety and Biosecurity Market in 2025?

North America dominated the biosafety and biosecurity market with the largest share in 2025. This is mainly due to its well-established public health infrastructure, strong research and development ecosystem, and substantial government and private-sector investments. The region benefits from advanced clinical networks and leading research institutions, which drive continuous demand for high-quality laboratory infrastructure, diagnostics, and containment solutions. Additionally, supportive regulatory frameworks, the presence of major industry players, and strong funding for innovation further reinforce its market leadership.

U.S. Biosafety and Biosecurity Market Size and Growth 2026 to 2035

The U.S. biosafety and biosecurity market size is calculated at USD 4.70 billion in 2025 and is expected to reach nearly USD 12.21 billion in 2035, accelerating at a strong CAGR of 10.02% between 2026 and 2035.

U.S. Market Analysis

The U.S. is a major contributor to the North American market due to rising investments in healthcare infrastructure, advanced research in biotechnology and life sciences , and increasing preparedness for infectious disease outbreaks. Strong government funding from agencies such as the CDC, NIH, and Department of Defense is accelerating the development of high-containment laboratories, surveillance systems, and biosecurity technologies. Additionally, the presence of leading research institutions, strict regulatory standards, and rapid adoption of advanced technologies like AI-driven monitoring systems are further driving market expansion.

How is the Opportunistic Rise of Asia Pacific in the Biosafety and Biosecurity Market?

Asia Pacific is expected to grow at the fastest rate in the coming years due to expanding healthcare infrastructure, increasing government focus on infectious disease preparedness, and growing investments in life sciences research. Rapid industrialization and frequent outbreaks of emerging diseases have highlighted the need for stronger laboratory safety systems, surveillance networks, and containment facilities across countries such as China, India, Japan, and South Korea. Additionally, rising pharmaceutical and biotechnology manufacturing, along with cost-effective production capabilities, is attracting global players and driving demand for advanced biosafety and biosecurity solutions in the region.

China Market Analysis

The biosafety and biosecurity market in China is growing due to strong government investments in public health infrastructure and the rapid expansion of biotechnology and pharmaceutical research. The country's focus on enhancing disease surveillance, laboratory safety standards, and epidemic preparedness, especially after recent global health crises, has significantly increased demand for advanced containment and monitoring systems. Additionally, large-scale biomanufacturing capabilities, supportive national policies, and growing R&D activities in life sciences are further accelerating market growth.

Biosafety and Biosecurity Market Companies

• Thermo Fisher Scientific
• Eppendorf AG
• Sartorius AG
• Merck KGaA (MilliporeSigma)
• Danaher Corporation
• 3M Company
• Bio-Rad Laboratories 
• Panasonic Healthcare / PHC Corporation
• Labconco Corporation
• The Baker Company
• Getinge AB
• GEA Group AG
• Becton Dickinson (BD)
• Steris plc
• Honeywell International Inc.
• Abbott Laboratories
• Charles River Laboratories
• AseptiQuip, Inc.
• Cardinal Health
• ThermoGenesis Holdings

Segments Covered in the Report

By Product Type

• Biocides & Disinfectants
• Personal Protective Equipment (PPE)
• Detection & Monitoring Equipment
• Decontamination System
• Others (software, air filtration, barriers)

By Application/Use Case

• Infectious Disease Research 
• Vaccine & Drug Development 
• Diagnostic Laboratories
• Biodefense & Biosecurity Programs 
• Environmental Monitoring

By End-User

• Government & Regulatory Bodies
• Healthcare Institutions
• Agriculture Sector
• Research & Academia
• Private & Commercial Sector

By Distribution Channel

• Direct Sales
• Distributors & Dealers
• Government Procurement
• Online/E-commerce
• Specialty Stores

By Application

• Healthcare & Infection Control
• Agricultural Biosecurity
• Laboratory & Research Safety
• Industrial & Commercial Safety
• Public Safety & Surveillance

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa